1Cademy - Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan–implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2

Learn Before

SARS-CoV-2 Antibody Testing by Geographic Location

Reference

Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan–implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2

This MedRxiv Paper fully titled "Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan–implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2" investigates how long antibodies against SARS-CoV-2 last in the body.

Found that IgG prevalence increased significantly by age among healthcare workers and general workers, but that otherwise rates were low. Very few healthcare providers had IgG antibodies to SARS-CoV-2, though a significant proportion of them had been infected with the virus. After SARS-CoV-2 infection, people are unlikely to produce long-lasting protective antibodies against this virus.
Has significant implications for herd immunity, antibody-based therapeutics, public health strategies, and vaccine development.
Also has findings that refute the possibility of using SARS-CoV anitbody therapies for SARS-CoV-2

https://www.medrxiv.org/content/10.1101/2020.06.13.20130252v1.full.pdf

0

1

Updated 2020-07-27

Contributors are: